Aim: To develop a peptide/phospholipid hybrid system for gastrin-releasing peptide receptor (GRPR)-targeted delivery of pDNA or siRNA. Materials & methods: A multifunctional GRPR-targeted peptide R-9-K(GALA)-BBN(6-14) was combined with a phospholipid oligonucleotide delivery system (1:1 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine and 1,2-dioleoyl-3-trimethylammonium-propane) and evaluated for pDNA and siRNA delivery in terms of complex size, toxicity, receptor-targeted delivery and gene expression or knockdown efficiency. Results: By combining peptide and phospholipid delivery systems, synergistic improvements in gene expression and knockdown were observed when compared with either system alone. The optimized formulation demonstrated high...
We developed and tested a multicomponent peptide-woven siRNA nanocomplex (PwSN) comprising different...
In recent decades, the spectrum of available therapeutics has been expanded by the ever-growing fiel...
The targeting of gastrin-releasing peptide receptors (GRPR) was recently proposed for targeted thera...
Delivering siRNA is challenging due to many obstacles, such as extremely short in vivo half-life, ra...
Advances in nanomedicine bring the attention of researchers to the molecular targets that can play a...
The drug development of siRNA has been seriously hindered by the lack of an effective, safe and clin...
Targeted tumour therapy has proved to be an efficient alternative to overcome the limitations of con...
Although small interfering RNAs (siRNAs) have been demonstrated to specifically silence their target...
© 2014 The American Society of Gene and Cell Therapy. Protein-based methods of targeted short-interf...
The development of polymer-based nanoparticulate delivery systems for siRNA is important for the cli...
Gastrin-releasing peptide receptor (GRPR), a member of the G protein-coupled receptor superfamily, h...
Gastrin-releasing peptide receptor (GRPR), a member of the G protein-coupled receptor super-family, ...
RNA interference has been used to dissect the importance of individual gene products in various huma...
Protein-based methods of targeted short-interfering RNA (siRNA) delivery have the potential to solve...
<div><p>We developed and tested a multicomponent peptide-woven siRNA nanocomplex (PwSN) comprising d...
We developed and tested a multicomponent peptide-woven siRNA nanocomplex (PwSN) comprising different...
In recent decades, the spectrum of available therapeutics has been expanded by the ever-growing fiel...
The targeting of gastrin-releasing peptide receptors (GRPR) was recently proposed for targeted thera...
Delivering siRNA is challenging due to many obstacles, such as extremely short in vivo half-life, ra...
Advances in nanomedicine bring the attention of researchers to the molecular targets that can play a...
The drug development of siRNA has been seriously hindered by the lack of an effective, safe and clin...
Targeted tumour therapy has proved to be an efficient alternative to overcome the limitations of con...
Although small interfering RNAs (siRNAs) have been demonstrated to specifically silence their target...
© 2014 The American Society of Gene and Cell Therapy. Protein-based methods of targeted short-interf...
The development of polymer-based nanoparticulate delivery systems for siRNA is important for the cli...
Gastrin-releasing peptide receptor (GRPR), a member of the G protein-coupled receptor superfamily, h...
Gastrin-releasing peptide receptor (GRPR), a member of the G protein-coupled receptor super-family, ...
RNA interference has been used to dissect the importance of individual gene products in various huma...
Protein-based methods of targeted short-interfering RNA (siRNA) delivery have the potential to solve...
<div><p>We developed and tested a multicomponent peptide-woven siRNA nanocomplex (PwSN) comprising d...
We developed and tested a multicomponent peptide-woven siRNA nanocomplex (PwSN) comprising different...
In recent decades, the spectrum of available therapeutics has been expanded by the ever-growing fiel...
The targeting of gastrin-releasing peptide receptors (GRPR) was recently proposed for targeted thera...